What to question about supplementsAugust 31, 2023In 2020, the global veterinary dietary supplements market size swelled to $1.6 billion. The top conditions targeted for animals include joint health, liver health, immune function, and digestion.
SPONSORED CONTENTProtect your patients from the start.Simparica Trio (sarolaner, moxidectin, and pyrantel chewable tablets) is the first monthly preventative of its kind. Combining three ingredients for month-long protection. + Learn more
Approaching pets with behavior issuesAugust 30, 2023Growing awareness among both veterinarians and pet owners about the importance of treating behavioral issues in pets, a better understanding of the root causes of undesirable behaviors, and a comprehensive approach to treating them are resulting in more companion animals being successfully treated.
Old and new thoughts on infection controlAugust 29, 2023Surgical site infections (SSIs) are defined by the Centers for Disease Control and Prevention (CDC) as: superficial incisional (less than 30 days), deep incisional (30 days to 12 months), or organ space (30 days to 12 months).
Implementing AAHA-guided senior careAugust 29, 2023Staged senior healthcare plans, with the outcomes of maintaining quality of life (QOL), human-animal bond, and shared decision-making with the pet owner, can allow for proactive strategies for individual senior dog or cat needs.
Canine respiratory, digestive disease 'strongly linked,' study saysAugust 28, 2023Dogs with respiratory disease are at higher risk of digestive system abnormalities, according to new research published by the University of Missouri (MU) College of Veterinary Medicine (CVM).
Screening program supports diabetes management in dogs, catsAugust 22, 2023Merck Animal Health, Purina, and Zoetis continue diabetes education and screening program, now in its ninth year.
Controlling tumor growth target of cancer trialAugust 18, 2023 Improving outcomes for dogs afflicted with a particularly aggressive and fatal type of cancer is the goal of a clinical trial currently underway. A newly funded study will evaluate the potential of a cancer drug to control tumor growth for dogs with histiocytic sarcoma. The multi-center clinical trial, which is being conducted at Michigan State University (MSU), University of Florida, University of Wisconsin, and Virginia Tech, will be funded by the Bernese Mountain Dog Club of America (BMDCA) through Morris Animal Foundation's Donor-Inspired Study program. Histiocytic sarcoma was first described in Bernese mountain dogs in the late 1970s, but has since been noted in many other breeds, Morris Animal Foundation reports. "Histiocytic sarcoma is a devastating disease, and traditional chemotherapeutic drugs have shown limited success in improving treatment outcomes, especially with the disseminated form of the disease," says the study's principal investigator, Vilma Yuzbasiyan-Gurkan, PhD, a professor of microbiology, molecular genetics, and small animal clinical sciences at MSU. "Based on our studies of the molecular pathways driving tumor growth, we now have an opportunity to use a targeted approach in …
Implementing the 'OA pyramid of care'August 17, 2023As we know, a client may need to hear about your OA concerns several times before it registers, and the best time to start the conversation is when your patient is healthy, before the disease process may have begun.
Florida vet imposter arrested after causing dog's deathAugust 14, 2023A Florida dog groomer who posed as a veterinarian has been arrested after a Chihuahua he performed a caesarean section on died post-surgery.
Use caution during surgery near salivary ductsAugust 14, 2023Recommendations to help minimize the chances of abnormal accumulation of saliva include identifying the salivary gland openings (papillae) prior to making incisions and carefully raising flaps.
